Journals / Gülhane Askeri Tıp Akademisi Bülteni / 1997 / Cilt: 39 - Sayı: 3

Antibody responses in children vaccinated with tetanos protein conjugated haemophilus influenza type B vaccine

Tetanos proteini ile konjuge haemophilus influenzae tip B aşısı uygulanan çocuklarda meydana gelen antikor yanıtları

Pages
294–298
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, we think that both early (between two and four months) and late (between 15 and 18 months) administrations of PRP-T vaccine together with DTP-OPV are protective against invasive Hib infections.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Antibody Responses in Children Vaccinated with Tetanos Protein Conjugated Haemop¬hilus Influenza TypeB Vaccine We evaluated anti-PRP IgG levels occuring in response to vaccination together with diphteria-tetanüs-pertussis and oral polio vaccine (DTP/OPV), and tetanus protein conjugated Haemophilus influ¬enzae type B (Hib) vaccine (PRP-T) in infants at two and four months of age (Group I, n=20) and 15-18 months of age (Group II, n=17).
📊
Key Findings & Data:An antibody response of >1 ixg/ml was detected in 65 % of cases after the third vaccination dose and in 95 % after the boosterdose in Group I.
💡
Conclusion & Impact:In conclusion, we think that both early (between two and four months) and late (between 15 and 18 months) administrations of PRP-T vaccine together with DTP-OPV are protective against invasive Hib infections.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Antibody Responses in Children Vaccinated with Tetanos Protein Conjugated Haemop¬hilus Influenza TypeB Vaccine We evaluated anti-PRP IgG levels occuring in response to vaccination together with diphteria-tetanüs-pertussis and oral polio vaccine (DTP/OPV), and tetanus protein conjugated Haemophilus influ¬enzae type B (Hib) vaccine (PRP-T) in infants at two and four months of age (Group I, n=20) and 15-18 months of age (Group II, n=17). An antibody response of >1 ixg/ml was detected in 65 % of cases after the third vaccination dose and in 95 % after the boosterdose in Group I. This ratio was 91.6 % in Group II vaccinated between 15 and 18 months of age. Postvaccination anti PRP IgG levels after the second dose in Group I and after the single dose in Group II were statistically higher than those of their prevaccination levels. Co-administration of DTP/OPV and PRP-T vaccines did not cause an additional side effect. In conclusion, we think that both early (between two and four months) and late (between 15 and 18 months) administrations of PRP-T vaccine together with DTP-OPV are protective against invasive Hib infections.

Özet

GATA Çocuk Sağlığı ve Hastalıkları ABD Polikli-niği'ne rutin aşılama için başvuran 2-4 aylık (Grup I, n=20) ve rapel aşı için başvuran 15-18 aylık infant-larda (Grup II, n=17) rutin difteri-boğmaca-tetanos ve oral polio aşıları ile (DBT/Polio) birlikte tetanos proteini içeren konjuge Haemophilus influenzae tip-B (Hib) aşısı (PRP-T) yapıldıktan sonra oluşan anti-PRP IgG düzeyleri saptandı. Grup l'de üçüncü doz aşıdan sonra % 65, rapel sonrasında ise % 95 oranında, 1 ng/ml ve üzeri konsantrasyonlarda antikor cevabı elde edildi. 15-18. ayda tek doz yapılan aşıdan sonra bu oran, % 91.6 idi. Grup l'de ikinci doz aşıdan sonra, Grup ll'de ise tek doz aşıdan sonra bulunan değerler, aşı öncesi değerlere göre istatistiksel olarak anlamlıydı (p

🔖

Cite This Article

AKIN, R., OKUTAN, V., ALBAY, A., GÖKÇAY, E., SAKALLIOĞLU, O. (2022). Antibody responses in children vaccinated with tetanos protein conjugated haemophilus influenza type B vaccine. Gülhane Askeri Tıp Akademisi Bülteni, Cilt: 39 - Sayı: 3, 294–298. https://ajindex.com/articles/526685